ASCO 2024 Meeting Highlights
In This Article
- The American Society of Clinical Oncology (ASCO) Annual Meeting brings together thousands of international oncology professionals to share updates on clinical advances across every area of cancer research
- In these videos, Mass General Cancer Center Physician-Scientists Priscilla Brastianos, MD, Lecia Sequist, MD, MPH, and Jessica Lin, MD, share highlights from the ASCO 2024 conference
- They discuss encouraging results from a clinical trial for patients with high grade meningiomas, a new treatment for stage III unresectable EGFR lung cancer, and a palliative care trial
At this year's American Society of Clinical Oncology (ASCO) Annual Meeting, several Mass General Cancer Center leaders presented exciting updates in research and clinical advancements. In these videos, physician-scientists Priscilla Brastianos, MD, Lecia Sequist, MD, MPH, and Jessica Lin, MD, share highlights from their presentations at ASCO 2024.
Subscribe to the latest updates from Cancer Center Advances in Motion
Dr. Brastianos, director of the Central Nervous System Metastasis Center, presented encouraging results from a clinical trial for patients with high grade meningiomas. Dr. Sequist, program director of the Cancer Early Detection and Diagnostics Clinic, shared a new treatment for stage III unresectable EGFR lung cancer. Finally, Dr. Lin, attending physician in the Center for Thoracic Cancers and the Termeer Center for Targeted Therapies, discussed a palliative care trial co-led by Mass General Cancer Center Principal Investigators Joseph Greer, PhD, and Jennifer Temel, MD.
Dr. Brastianos: Alliance Clinical Trial
Dr. Sequist: Unresectable EGFR Lung Cancer
Dr. Lin: Palliative Care & Telehealth
Read more about Mass General Cancer Center at ASCO 2024
Learn about cancer care at Mass General